NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ:BBNX). Such
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of common stock of Beta Bionics, Inc. (NASDAQ:BBNX) between July 30, 2025 and February 24, 2026. Beta
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SueWallSt reminds purchasers of Beta Bionics, Inc. (NASDAQ:BBNX) securities that a securities class action has been filed on behalf of shareholders who acquired shares
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options
If you purchased or acquired
LOS ANGELES, Nov. 03, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in Beta Bionics, Inc. (NASDAQ:BBNX) that a securities class action lawsuit has been filed on behalf of shareholders who purchased
IRVINE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will participate at
New York, New York--(Newsfile Corp. - November 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ:BBNX) between July 30, 2025 and February
NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ:BBNX) between July 30, 2025 and February 24, 2026,
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you purchased or acquired
NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company")
NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP alerts investors in Beta Bionics, Inc. (NASDAQ:BBNX) that Chief Executive Officer Sean Saint and Chief Financial Officer Stephen Feider are named
New York, New York--(Newsfile Corp. - November 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company")
New York, New York--(Newsfile Corp. - November 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ:BBNX) between July 30, 2025 and February
New York, New York--(Newsfile Corp. - October 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ:BBNX) between July 30, 2025 and February
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Beta Bionics (BBNX) To Contact Him Directly To Discuss Their Options If you purchased or acquired Beta
